- Home
- GILD vs UL Comparison
GILD vs UL Comparison
Compare GILD & UL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- UL
- Stock Information
- Founded
- GILD 1987
- UL 1930
- Country
- GILD United States
- UL United Kingdom
- Employees
- GILD N/A
- UL N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- UL Package Goods/Cosmetics
- Sector
- GILD Health Care
- UL Consumer Discretionary
- Exchange
- GILD Nasdaq
- UL Nasdaq
- Market Cap
- GILD 138.2B
- UL 151.6B
- IPO Year
- GILD 1992
- UL N/A
- Fundamental
- Price
- GILD $111.79
- UL $59.17
- Analyst Decision
- GILD Buy
- UL Strong Buy
- Analyst Count
- GILD 27
- UL 4
- Target Price
- GILD $105.32
- UL $66.00
- AVG Volume (30 Days)
- GILD 10.7M
- UL 2.5M
- Earning Date
- GILD 04-24-2025
- UL 04-08-2025
- Dividend Yield
- GILD 2.83%
- UL 3.17%
- EPS Growth
- GILD N/A
- UL N/A
- EPS
- GILD 0.38
- UL 2.37
- Revenue
- GILD $28,754,000,000.00
- UL $62,906,097,959.00
- Revenue This Year
- GILD $1.77
- UL $5.65
- Revenue Next Year
- GILD $3.52
- UL $3.05
- P/E Ratio
- GILD $294.18
- UL $25.00
- Revenue Growth
- GILD 6.04
- UL 1.94
- 52 Week Low
- GILD $62.07
- UL $46.46
- 52 Week High
- GILD $119.96
- UL $65.87
- Technical
- Relative Strength Index (RSI)
- GILD 57.43
- UL 57.12
- Support Level
- GILD $104.70
- UL $57.67
- Resistance Level
- GILD $107.42
- UL $59.29
- Average True Range (ATR)
- GILD 2.48
- UL 0.56
- MACD
- GILD -0.62
- UL -0.07
- Stochastic Oscillator
- GILD 57.74
- UL 62.29
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About UL Unilever PLC
Unilever is a diversified personal-care (52% of 2022 sales by value), homecare (14%), and packaged food (34%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Axe and Dove skin products, and the TRESemmé haircare brand. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, Garancia, and The Vegetarian Butcher.